Tags Archive Navigation
icon
-
Media ReleaseNovartis receives EC approval for new Xolair® indication to treat severe chronic rhinosinusitis with nasal polyps
-
Media ReleaseFDA approves Novartis Kesimpta® (ofatumumab), the first and only self-administered, targeted B-cell therapy for patients with relapsing multiple sclerosis
-
Media ReleaseNovartis new analysis shows high consistency in lowering LDL-C in individual response with investigational inclisiran
-
StoryPhotographer Captures Patients Around the World Persevering With ITP
-
StoryA blood cancer patient’s long road to diagnosis
-
StoryYour Genes, Your Melanoma
-
StoryT.J. Sharpe on why clinical trials matter
-
StorySpeaking Up in CML
-
StoryReimagining asthma care: how data and digital could bring asthma management goals within reach
-
StoryThe realities of living with premenopausal metastatic breast cancer
-
StoryParenting a child with a rare disease
-
StoryOne boy’s quest to battle cancer
Pagination
- ‹ Previous page
- 1
- …
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- › Next page